Contact
Iproteos has been a semi-finalist in the II Award for the Best Entrepreneurial Biotechnology Project, a technology transfer prize given by the Spanish Society of Biochemistry (Sociedad Española de Bioquímica (SEBBM)). The spin-off, which is promoted by IRB Barcelona –located at the Barcelona Science Park- and the University of Barcelona –through the Bosch y Gimpera Foundation, also at the Park – was founded in June with the mission to develop and commercialize a new generation of more efficient low cost drugs with fewer side effects.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
